LONDON, Feb 13 (Reuters) - European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.



Latest News

USA Today: The Latest: Niskanen wins Finland's first Pyeongchang gold

Daily Mail: Russian bobsledder Sergeeva admits to doping at Olympics

Daily Mail: Cody Simpson looks biker chic riding his motorcycle in LA

Daily Mail: Karlsson nets two goals, Vegas beats Canucks, 6-3

Ynet: IS claims responsibility for Afghan bombing

Daily Mail: Winter Olympics: Billy Morgan bronze seals Team GB record

CBC: Canadian athlete arrested, released after alleged drunken car theft

USA Today: Snowboarder Mark McMorris' tale of perseverance inspires students in India

Daily Mail: NRA faces corporate backlash after latest US school...

Daily Mail: Gwyneth Paltrow dons black jacket and trouser combo

Haaretz: 'Israelis have changed, they hate more and are more insular'

USA Today: The Latest: Russia bobsledder admits doping, is disqualified

USA Today: Snowboarder Mark McMorris' tale of perseverance inspires students in India

Reuters: Australian PM declines to offer Trump any advice on gun control

Daily Mail: Philippine Catholics protest bill to legalise divorce

Daily Mail: Father takes helicopter to view birth of son

FOX: Whack with liquor bottle killed Kat West, court records say

Daily Mail: Eight dead in 32 hours as fatal crashes on NSW roads soar

Daily Mail: Saudi oil minister hopes OPEC, allies will ease output...

Reuters: Militants attack Afghan army post killing 18 soldiers

BBC: Newport father's plea over A48 hit-and-run crash

CBC: Golden Knights overpower Canucks to reclaim 1st place in standings

USA Today: Postcard-perfect images of Norway